Market Cap: $2.47B
BI
Beam Therapeutics Inc.
BEAM
NASDAQ (NASDAQ Global Select)USD
Market Cap: $2.47B
Analysts estimated BEAM earnings of $-1.12 per share this quarter (Q1). BEAM's actual earnings were $-0.91 per share.
BEAM EPS surprise of 18.57%Analysts estimated BEAM earnings of $-1.01 per share this quarter (Q4). BEAM's actual earnings were $-0.10 per share.
BEAM EPS surprise of 89.82%Analysts estimated BEAM earnings of $-1.13 per share this quarter (Q2). BEAM's actual earnings were $-1.00 per share.
BEAM EPS surprise of 11.65%Analysts estimated BEAM earnings of $-1.23 per share this quarter (Q4). BEAM's actual earnings were $-1.09 per share.
BEAM EPS surprise of 11.25%Analysts estimated BEAM earnings of $-1.45 per share this quarter (Q1). BEAM's actual earnings were $-1.21 per share.
BEAM EPS surprise of 16.31%Analysts estimated BEAM earnings of $-1.03 per share this quarter (Q4). BEAM's actual earnings were $1.73 per share.
BEAM EPS surprise of -267.72%